177 related articles for article (PubMed ID: 29039849)
1. Targeted metabolomics and medication classification data from participants in the ADNI1 cohort.
St John-Williams L; Blach C; Toledo JB; Rotroff DM; Kim S; Klavins K; Baillie R; Han X; Mahmoudiandehkordi S; Jack J; Massaro TJ; Lucas JE; Louie G; Motsinger-Reif AA; Risacher SL; ; ; Saykin AJ; Kastenmüller G; Arnold M; Koal T; Moseley MA; Mangravite LM; Peters MA; Tenenbaum JD; Thompson JW; Kaddurah-Daouk R
Sci Data; 2017 Oct; 4():170140. PubMed ID: 29039849
[TBL] [Abstract][Full Text] [Related]
2. Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.
St John-Williams L; Mahmoudiandehkordi S; Arnold M; Massaro T; Blach C; Kastenmüller G; Louie G; Kueider-Paisley A; Han X; Baillie R; Motsinger-Reif AA; Rotroff D; Nho K; Saykin AJ; Risacher SL; Koal T; Moseley MA; Tenenbaum JD; Thompson JW; Kaddurah-Daouk R; ;
Sci Data; 2019 Oct; 6(1):212. PubMed ID: 31624257
[TBL] [Abstract][Full Text] [Related]
3. Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort.
Barupal DK; Fan S; Wancewicz B; Cajka T; Sa M; Showalter MR; Baillie R; Tenenbaum JD; Louie G; ; ; Kaddurah-Daouk R; Fiehn O
Sci Data; 2018 Nov; 5():180263. PubMed ID: 30457571
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Metabolomics in Alzheimer's Disease: Technical Considerations for Improved Reproducibility.
Veiga S; Wahrheit J; Rodríguez-Martín A; Sonntag D
Methods Mol Biol; 2018; 1779():463-470. PubMed ID: 29886550
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
Yi L; Liu W; Wang Z; Ren D; Peng W
Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
[TBL] [Abstract][Full Text] [Related]
6. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
8. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
[TBL] [Abstract][Full Text] [Related]
9. Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
Yin C; Harms AC; Hankemeier T; Kindt A; de Lange ECM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902391
[TBL] [Abstract][Full Text] [Related]
10. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
[TBL] [Abstract][Full Text] [Related]
11. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.
Spellman DS; Wildsmith KR; Honigberg LA; Tuefferd M; Baker D; Raghavan N; Nairn AC; Croteau P; Schirm M; Allard R; Lamontagne J; Chelsky D; Hoffmann S; Potter WZ; ;
Proteomics Clin Appl; 2015 Aug; 9(7-8):715-31. PubMed ID: 25676562
[TBL] [Abstract][Full Text] [Related]
13. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Structural Brain Changes in Early-Onset Alzheimer's Disease Subjects Using the LONI Pipeline Environment.
Moon SW; Dinov ID; Hobel S; Zamanyan A; Choi YC; Shi R; Thompson PM; Toga AW;
J Neuroimaging; 2015; 25(5):728-37. PubMed ID: 25940587
[TBL] [Abstract][Full Text] [Related]
16. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
[TBL] [Abstract][Full Text] [Related]
17. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
18. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
Xu L; Wu X; Chen K; Yao L
Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
[TBL] [Abstract][Full Text] [Related]
19. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
